Candel Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CADL and other ETFs, options, and stocks.About CADL
Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110.
CEOPaul-Peter Tak
CEOPaul-Peter Tak
Employees38
Employees38
HeadquartersNeedham, Massachusetts
HeadquartersNeedham, Massachusetts
Founded2002
Founded2002
Employees38
Employees38
CADL Key Statistics
Market cap309.63M
Market cap309.63M
Price-Earnings ratio-10.10
Price-Earnings ratio-10.10
Dividend yield—
Dividend yield—
Average volume645.73K
Average volume645.73K
High today$5.76
High today$5.76
Low today$5.52
Low today$5.52
Open price$5.71
Open price$5.71
Volume688.99K
Volume688.99K
52 Week high$13.68
52 Week high$13.68
52 Week low$4.25
52 Week low$4.25
Stock Snapshot
With a market cap of 309.63M, Candel Therapeutics(CADL) trades at $5.65. The stock has a price-to-earnings ratio of -10.10.
As of 2026-01-01, Candel Therapeutics(CADL) stock has fluctuated between $5.52 and $5.76. The current price stands at $5.65, placing the stock +2.4% above today's low and -1.9% off the high.
The Candel Therapeutics(CADL)'s current trading volume is 688.99K, compared to an average daily volume of 645.73K.
In the last year, Candel Therapeutics(CADL) shares hit a 52-week high of $13.68 and a 52-week low of $4.25.
In the last year, Candel Therapeutics(CADL) shares hit a 52-week high of $13.68 and a 52-week low of $4.25.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own CADL. This list is generated using Robinhood data, and it’s not a recommendation.